In Experiment III, animals were administered three weekly injections of AOM and then separated into four groups that received 2 or 0.2% bLf, 2% bLf hydrolysate, or 0.1% bovine lactoferricin (bLfcin) for 36 weeks. Here, LTF is linked to infectious otitis media.